BioVie Inc. Class A Common Stock (BIVI)
Stock · NASDAQ · Health Care
$2.16as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$1.35
Industry
Biotechnology: Pharmaceutical Preparations
About BIVI
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's di…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- bioviepharma.com
Fundamentals
- 1-day range
- $1.25$1.52
- Market cap
- $12.22M
- P/E (trailing)
- —
- P/E (forward)
- -2.46
- EPS (trailing)
- $-3.05
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 2.57M
- Dividend pay date
- November 22, 2019
52-week range
$0.82$3.79
Next earnings: August 24, 2026 · EPS estimate $-0.52confirmed
Forecasts
2 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$5.51
+155.1%
Median
$5.26
+143.3%
Low
$5
+131.5%
BioVie Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- BIVIBioVie Inc. Class A Common Stock$2.16▼ 1.37%Market cap $12.22MP/E —$0.82$3.79
- PHIOPhio Pharmaceuticals Corp. Common Stock$1.13▲ 0.45%Market cap $11.97MP/E —$0.8127$4.19
- AKTXAkari Therapeutics plc ADS$11.03▲ 22.42%Market cap $12.88MP/E Infinity$3.02$49.6
- COCPCocrystal Pharma Inc. Common Stock$1.11▼ 2.63%Market cap $12.96MP/E —$0.76$2.67
- AEONAEON Biopharma Inc. Class A Common Stock$0.3095▲ 5.27%Market cap $14.41MP/E —$0.1772$1.45
- PTNPalatin Technologies Inc. Common Stock$10.48▼ 0.10%Market cap $14.64MP/E 85.09$5.61$31
- KTTAPasithea Therapeutics Corp. Common Stock$0.5975▲ 7.66%Market cap $14.92MP/E —$0.281$2.06
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BIVI BioVie Inc. Class A Common Stock | $12.22M | — | $2.16 | ▼ 1.37% | $0.82$3.79 |
| PHIO Phio Pharmaceuticals Corp. Common Stock | $11.97M | — | $1.13 | ▲ 0.45% | $0.8127$4.19 |
| AKTX Akari Therapeutics plc ADS | $12.88M | Infinity | $11.03 | ▲ 22.42% | $3.02$49.6 |
| COCP Cocrystal Pharma Inc. Common Stock | $12.96M | — | $1.11 | ▼ 2.63% | $0.76$2.67 |
| AEON AEON Biopharma Inc. Class A Common Stock | $14.41M | — | $0.3095 | ▲ 5.27% | $0.1772$1.45 |
| PTN Palatin Technologies Inc. Common Stock | $14.64M | 85.09 | $10.48 | ▼ 0.10% | $5.61$31 |
| KTTA Pasithea Therapeutics Corp. Common Stock | $14.92M | — | $0.5975 | ▲ 7.66% | $0.281$2.06 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Which stocks are moving before the opening bell on Friday?ChartMill · 8/21/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 8/21/2026
- Top movers analysis one hour before the close of the markets on 2026-08-20: top gainers and losers in today's session.ChartMill · 8/20/2026
- What's going on in today's sessionChartMill · 8/20/2026
- Which stocks are gapping on Thursday?ChartMill · 8/20/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 8/20/2026
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 8/20/2026
- Why Webull Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving PremarketBenzinga · 8/20/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 993.3K
- Total value held
- $1.25M
- Institutional holders
- 30
Top holders this quarter
- Unknown370.0K
- Unknown92.1K
- Unknown84.2K
- Unknown84.1K
- Unknown75.2K
- Unknown75.0K
- Unknown67.9K
- Unknown45.3K
- Unknown23.5K
- Unknown22.8K
See the full, filterable feed with live charts on the MarketWall dashboard.